Showing results (1-10 of 406) with videos related to
Sort By:
Pageof 41
European Journal of Cancer (Oxford, England : 1990)|November 19, 2005
Peripheral neuropathy: a persisting challenge in paclitaxel-based regimesStephan Mielke, Alex Sparreboom, Klaus MrossAnticancer Research|December 13, 2005
Paclitaxel pharmacokinetics and response to chemotherapy in patients with advanced cancer treated with a weekly regimenStephan Mielke, Alex Sparreboom, Dirk Behringer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancerStephan Mielke, Alex Sparreboom, Seth M Steinberg, et al.European Journal of Cancer (Oxford, England : 1990)|September 5, 2006
Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropeniaTristan M Sissung, Klaus Mross, Seth M Steinberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Comparative pharmacokinetics of unbound paclitaxel during 1- and 3-hour infusionsHans Gelderblom, Klaus Mross, Albert J ten Tije, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxelAnja Henningsson, Sharon Marsh, Walter J Loos, et al.Anti-Cancer Drugs|November 5, 2003
Comparative neurotoxicity of weekly non-break paclitaxel infusions over 1 versus 3 hStephan Mielke, Klaus Mross, Thomas A Gerds, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Anti-angiogenesis therapy:concepts and importance of dosing schedules in clinical trialsKlaus MrossJournal of Angiogenesis Research|June 24, 2010
Clinical trials with anti-angiogenic agents in hematological malignanciesMichael Medinger, Klaus MrossCurrent Opinion in Oncology|October 2, 2007
Individualized pharmacotherapy with paclitaxelStephan MielkePageof 41